Frontlight ResearchEarly access
Colorectal cancer trials in United States
551 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
- Where
- Basking Ridge, Commack, Harrison, New York
- Age
- 18 years and over
- People
- 80
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03432806 - No phaseTaking peopleTier - Palliative Care For Patients With Advanced Heart Failure or Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 60
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06228209 - No phaseNot yet taking people in United StatesCollagenase Biobank Study
- Where
- Chicago
- Age
- 18 years and over
- People
- 107
- Run by
- University of Chicago
See details and how to joinNCT07211230 - Phase 1/2Taking peopleA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Where
- Fairfax, Huntersville, New York, San Antonio
- Age
- 18 years and over
- People
- 499
- Run by
- Arvinas Inc.
See details and how to joinNCT07749586 · EU 2026-525614-57-00 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Where
- Columbia
- Age
- 18 years and over
- People
- 320
- Run by
- University of Missouri-Columbia
See details and how to joinNCT03551951 - No phaseTaking peopleAn Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 80
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05914766 - Phase 2Taking peopleA Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Where
- Ann Arbor, Austin, Baltimore, Boston, Chicago, Durham, Fairfax, Fort Worth, Fullerton, Grapevine, Houston, Huntsville, Jacksonville, Lake Success, Los Angeles, Minneapolis, Nashville, Philadelphia, Portland, Rochester, Tampa
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- AbbVie
See details and how to joinNCT07023289 · EU 2024-518015-19-00 - Phase 1Taking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Princeton
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - Phase 3Taking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Aberdeen, Abilene, Albany, Albuquerque, Amarillo, Arlington, Arlington Heights, Athens, Auburn, Aurora, Babylon, Baltimore, Beaumont, Berkeley, Big Rapids, Blacksburg, Bloomington, Boise, Bonita Springs, Bonney Lake, Boston, Boulder, Bradenton, Brandon, Brooklyn, Camillus, Cape Coral, Cary, Centennial, Chandler, Chicago, Cincinnati, Clackamas, Cleveland, Clifton Park, Colorado Springs, Coral Springs, Corvallis, Denison, Denton, Denver, Durham, East Syracuse, Edmonds, Elizabethtown, El Paso, Encinitas, Englewood, Eugene, Fairfax, Fairfield, Fayetteville, Federal Way, Flower Mound, Fort Myers, Foxborough, Frankfort, Fremont, Galesburg, Gig Harbor, Gilbert, Glendale, Goodyear, Grand Rapids, Greeley, Henderson, Hillsboro, Hinsdale, Holland, Houston, Humble, Indianapolis, Irving, Issaquah, Jacksonville, Kennewick, La Jolla, Lakewood, Largo, Las Vegas, Lexington, Lincoln, Littleton, Lone Tree, Longmont, Longview, Louisville, Loveland, Low Moor, Manassas, Marshall, Mechanicsville, Melbourne, Mesa, Midland, Midlothian, Milford, Mitchell, Mooresville, Morris, Nampa, Naples, Nashville, New Hyde Park, New Lenox, Newton, New York, Niles, Norton Shores, N. Venice, Nyack, Odessa, Orange City, Ottawa, Palm Bay, Palm Harbor, Palo Alto, Patchogue, Pearland, Pekin, Peoria, Peru, Petersburg, Phoenix, Pierre, Port Charlotte, Port Jefferson Station, Portland, Pueblo, Puyallup, Raleigh, Reno, Reston, Richland, Richmond, Riverhead, Roanoke, Rochester, Rockledge, Rogers, Roseville, Sacramento, Salem, San Diego, San Francisco, San Mateo, Santa Rosa, Sarasota, Scottsdale, Seattle, Shirley, Sioux Falls, Springdale, Springfield, Stamford, St. Petersburg, Sugar Land, Sun City, Sunnyvale, Tacoma, Temple, The Bronx, The Woodlands, Thornton, Topsham, Trinity, Tyler, Vista, Washington, Westbrook, Wichita Falls, Woodbridge, Wytheville, Yankton
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - No phaseTaking peopleMolecular Basis for Variations in Hereditary Colorectal Cancer Syndromes
- Where
- Houston
- Age
- 18 years and over
- People
- 2,000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02863172 - Phase 1/2Taking peopleFOG-001 in Locally Advanced or Metastatic Solid Tumors
- Where
- Aurora, Baltimore, Boston, Charlottesville, Cleveland, Durham, Houston, Jacksonville, Lake Mary, Los Angeles, Madison, Minneapolis, Nashville, New Haven, New York, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, San Francisco, Santa Monica, Scottsdale, St Louis, Tucson, Washington D.C.
- Age
- 18 years and over
- People
- 619 worldwide
- Run by
- Parabilis Medicines, Inc.
See details and how to joinNCT05919264 - Phase 1Taking peoplePhase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 33
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT06833866 - Phase 2Taking people5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 57
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT06887218 - Phase 1Taking peopleStudy of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Where
- Boston, Charleston, Charlotte, Cleveland, Houston, La Jolla, Los Angeles, Nashville, New York, Pittsburgh, Providence, Sacramento, Tampa
- Age
- 18 years and over
- People
- 473 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT04429542 - No phaseTaking peopleA Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
- Where
- Columbus
- Age
- 18 years and over
- People
- 80
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT06424522 - Phase 2Taking peopleTrial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
- Where
- Houston
- Age
- 18 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06569368 - No phaseTaking peopleAdvocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 60
- Run by
- Stanford University
See details and how to joinNCT07403981 - No phaseTaking peopleDeveloping New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Where
- Brooklyn, Jamaica, New York, Richmond Hill
- Age
- 18 years and over
- People
- 445
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04751435 - Phase 2Taking peopleTrial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
- Where
- Lexington, Omaha, San Antonio
- Age
- 18 years and over
- People
- 118
- Run by
- University of Nebraska
See details and how to joinNCT05254327 - No phaseTaking peopleA Study of Mental Health Care in People With Cancer
- Where
- New York
- Age
- 65 years and over
- People
- 130
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06037954 - Phase 1/2Taking peopleDual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
- Where
- Houston
- Age
- 18 years and over
- People
- 28
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07411599 - Phase 1Taking peopleAVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Where
- Chicago, Fairfax, Grand Rapids, Irving, New York, Sarasota, Scottsdale
- Age
- 18 years and over
- People
- 174
- Run by
- Avacta Life Sciences Ltd
See details and how to joinNCT07454642 - Phase 1Taking peopleA Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Where
- Denver, Duarte, Irving, New York, Phoenix, San Antonio, San Diego
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Bayer
See details and how to joinNCT07535112 · EU 2025-523648-11-00 - Phase 1Taking peopleA Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Where
- Boston, Cincinnati, Duarte, Nashville, Newport Beach, Salt Lake City, Tampa
- Age
- 18 years and over
- People
- 66
- Run by
- Dispatch Biotherapeutics
See details and how to joinNCT07544589 - Phase 2Not yet taking people in United StatesHRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
- Where
- Rochester
- Age
- 18 years to 90 years
- People
- 80
- Run by
- Mayo Clinic
See details and how to joinNCT07612007